Last reviewed · How we verify
LianHuaQingWen Granules — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
LianHuaQingWen Granules (LianHuaQingWen Granules) — Guizhou Bailing Group Pharmaceutical Co Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LianHuaQingWen Granules TARGET | LianHuaQingWen Granules | Guizhou Bailing Group Pharmaceutical Co Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LianHuaQingWen Granules CI watch — RSS
- LianHuaQingWen Granules CI watch — Atom
- LianHuaQingWen Granules CI watch — JSON
- LianHuaQingWen Granules alone — RSS
Cite this brief
Drug Landscape (2026). LianHuaQingWen Granules — Competitive Intelligence Brief. https://druglandscape.com/ci/lianhuaqingwen-granules. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab